Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.

about

Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.

Item

http://www.wikidata.org/entity/Q36799355

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prolonged activation of human ...... daptation but not dysfunction.

@en

type

Item

label

Prolonged activation of human ...... daptation but not dysfunction.

@en

prefLabel

Prolonged activation of human ...... daptation but not dysfunction.

@en

P1476

Prolonged activation of human ...... daptation but not dysfunction.

@en

P2093

Alonso Vilches-Flores

http://www.w3.org/2001/XMLSchema#string

Astrid C Hauge-Evans

http://www.w3.org/2001/XMLSchema#string

Bo Liu

http://www.w3.org/2001/XMLSchema#string

Guo C Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Activation of the peripheral endocannabinoid system in human obesity

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The endocannabinoid system and energy metabolism

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets

CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health.

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.

P304

143-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBACLI.2016.03.009

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299543206

http://www.w3.org/2001/XMLSchema#string

P698

27114924

http://www.w3.org/2001/XMLSchema#string

P921

CNR2

cannabinoid receptor

cannabinoids

P932

4832123

http://www.w3.org/2001/XMLSchema#string